JANX in the 13F filings
Janux Therapeutics Inc · CUSIP 47103J105
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 26
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 1 listed it in both
- Shares listed
- 12,477,474
- combined, among listed positions
- Reported value
- $192m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 14 buyers (opened or added shares) and 13 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -1,739,790.
Managers listing JANX in Q2 2026
26 of 26 holders
Largest increases and reductions, by shares
Increases
- Two Sigma Investments LPexisting position · 1,207,250 shares now+1,091,151
- D. E. Shaw & Co.existing position · 1,096,509 shares now+998,114
- Citadel Advisors LLCexisting position · 1,200,737 shares now+848,560
- Point72 Asset Management LPexisting position · 1,993,837 shares now+837,697
- Jane Street Group LLCexisting position · 391,991 shares now+140,251
Reductions
- Janus Henderson Group Ltdexisting position · 172,229 shares now-4,024,180
- Balyasny Asset Management LLCexisting position · 211,635 shares now-878,512
- Woodline Partners LPexisting position · 370,032 shares now-368,000
- Fidelity (FMR LLC)existing position · 2,412,825 shares now-122,899
- ExodusPoint Capital Management LPexisting position · 10,079 shares now-104,493
New positions and exits
New (2)
Exited (1)
- Susquehanna International Group LLPwas $1.7m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2021 | 1 | $8.3m | n.a. | n.a. |
| Q3 2021 | 1 | $6.5m | n.a. | n.a. |
| Q4 2021 | 1 | $5.5m | n.a. | n.a. |
| Q1 2022 | 1 | $4.0m | n.a. | n.a. |
| Q2 2022 | 1 | $3.5m | n.a. | n.a. |
| Q3 2022 | 1 | $5.4m | n.a. | n.a. |
| Q4 2022 | 1 | $6.7m | n.a. | n.a. |
| Q1 2023 | 1 | $1.7m | n.a. | n.a. |
| Q2 2023 | 1 | $1.6m | n.a. | n.a. |
| Q3 2023 | 1 | $864k | n.a. | n.a. |
| Q1 2024 | 3 | $76m | 3 | 0 |
| Q2 2024 | 3 | $98m | 2 | 2 |
| Q3 2024 | 5 | $218m | 4 | 1 |
| Q4 2024 | 8 | $850m | 6 | 1 |
| Q1 2025 | 3 | $174m | 1 | 2 |
| Q2 2025 | 4 | $182m | 1 | 2 |
| Q3 2025 | 3 | $182m | 1 | 3 |
| Q4 2025 | 2 | $88m | 21 | 6 |
| Q1 2026 | 1 | $58m | 10 | 14 |
| Q2 2026 | 1 | $1.4m | 14 | 13 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
JANX and LLY →JANX and JNJ →JANX and VRTX →Choose a stock to compare with JANX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own JANX, latest filings →Back to the 13F Explorer →